Cephalosporin Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Cephalosporin Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Pharmaceutical

Report Description

1
1

Cephalosporin drugs are bactericidal beta lactam antibiotics. These prevent the growth of bacteria by inhibiting cell wall synthesis, which effective in both type of bacteria i.e., gram-positive and gram-negative. Cephalosporin was first prepared from a fungus named Cephalosporium acremonium by scientist Dr. Abraham in 1948. Cephalosporin drugs are considered broad-spectrum antibiotics having similar activities to those of ampicillin and often are considered an alternative to penicillin for many patients. Cephalosporin drugs are used to treat infections in different parts of the body such as lungs, ears, sinuses, nose, throat, and skin. Physicians also prescribe these drugs to treat pneumonia, staph infections, bronchitis, strep throat, tonsillitis, and gonorrhea. Cephalosporin drugs can be classified into five classes or generation depending upon antimicrobial activity. The gram-negative antimicrobial property significantly increases with each newer generation of cephalosporin. Hence, usage of cephalosporin in various disease conditions is likely to boost the growth of the global cephalosporin drugs market in the near future. These drugs are contraindicated in patients who are allergic to them or who have had an anaphylactic reaction to penicillin.

The global cephalosporin drugs market is expected to grow substantially due to increasing demand for anti-microbial in various indications, rising research and development activities, growing awareness among patients, increasing prevalence of infectious diseases, and special regulatory designation for pipeline molecule. Every year, November 18 is celebrated as the European Antibiotic Awareness Day, which helps to increase awareness about antibiotic resistance and promotes judicious use of antibiotics. Such programs about the disease and treatment options increase the treatment-seeking population, thereby boosting the growth of the market. Additionally, low investment in R&D, stringent government policies, and generic saturation of these drugs fuel the growth of the market. Moreover, increasing mergers and acquisitions, use of combination therapies for treatment, and development of safe and highly efficient cephalosporin drugs are other factors likely to contribute to the growth of the market. However, weak pipeline molecules, development of drug resistance and resistance by governments on drug development are some challenges in the global cephalosporin drugs market.

The cephalosporin drugs market has been segmented based on spectrum of antimicrobial activity and route of administration. In terms of spectrum of antimicrobial activity, the market has been segmented into first generation, second generation, third generation, fourth generation, and fifth generation. First generation cephalosporin generates higher revenue than others due to its effectiveness against gram-positive bacteria such as streptococci and staphylococci. These also have gram-negative spectrum antimicrobial activity. Based on route of administration, the market has been segmented into injection and oral. Injection is the most preferred route of drug administration due to quick drug delivery.

Geographically, the global cephalosporin drugs market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is sub-divided into countries such as the U.S., Canada, Germany, the U.K., Brazil, China, India, Japan, and GCC Countries. Asia Pacific dominated the global cephalosporin drugs market because of increasing awareness about cephalosporin drugs among patients, rising demand for highly developed health care infrastructure, and large population with infectious diseases. North America is considered to be the most attractive market due to rising prevalence of infectious diseases.

Key players operating in the cephalosporin drugs market are Astellas, Roche, Bristol-Myers Squibb, Lupin Pharmaceuticals, Glaxo SmithKline, Pfizer, Abbott, Ranbaxy, Merck, Sandoz, and Teva Pharmaceuticals, among others. In order to gain competitive advantage in the industry, major players are actively involved in various growth strategies. Collaborations, agreements, partnerships, and new product launches are some of the important strategies adopted by the market players.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients